Tatiana Karpova Karpova

Dr. Tatiana Karpova Karpova


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2024 in Journal of Engineering and Science in Medical Diagnostics and Therapy
Verified
Journal Article
Closed access
PDF file
YZYingnan Zhai
Yingnan Zhai
ZSZhenshan Shi
Zhenshan Shi
TPThyagaseely Premaraj
Thyagaseely Premaraj
SPSundaralingam Prem Premaraj
Sundaralingam Prem Premaraj
TKTatiana Karpova Karpova
Tatiana Karpova Karpova
Linxia GuLinxia Gu
Linxia Gu

Verified
Journal Article
Open access
PDF file
SRSwasti Rastogi
Swasti Rastogi
JLJessica Liaw
Jessica Liaw
YZYingnan Zhai
Yingnan Zhai
TKTatiana Karpova Karpova
Tatiana Karpova Karpova
Linxia GuLinxia Gu
Linxia Gu
KNKenia Pedrosa Nunes
Kenia Pedrosa Nunes
Hypertension, a leading factor for cardiovascular diseases (CVD), is a particularly heavy burden in women during middle age, when cardioprotective hormones begin to decline. The abnormal handling of calcium (Ca2+) in vascular smooth muscle cells (VSMCs) leads to increased vasoconstriction, remodeling, and altered arterial compliance during hypertension. The Spontaneously Hypertensive Rats (SHR) is a model of essential hypertension, and middle-aged females with hypertension represent a stage of disease where vascular dysfunction is prominent but understudied. Losartan, a widely prescribed angiotensin II (AngII) receptor (AT1R) blocker, exerts antihypertensive effects by affecting Ang II/Ca2+ signaling. However, whether it corrects the Ca2+ mishandling in the aorta of middle-aged female SHR has not been established. In this study, the thoracic aorta from 36-week-old female SHRs treated with losartan was assessed for Ca2+ mishandling using myography and biochemical assays. Meanwhile, biomechanical properties and stiffness were evaluated using Pulse Wave Velocity (PWV), Atomic Force Microscopy (AFM), and assessments of collagen and elastin contents. Compared with normotensive controls, SHR demonstrated disrupted Ca2+ handling, increased stiffness, and Extracellular Matrix (ECM) remodeling in middle-aged females. Treatment with losartan abrogated Ca2+ mishandling influx and efflux in the VSMC, decreased stiffness, and restored the aortic structural changes. These findings demonstrate that losartan abolishes Ca2+ mishandling and highlight a mechanistic role of AT1R blockade in restoring vascular function in the aorta of middle-aged females during hypertension.